News & Analysis on Clinical Trial Services & Contract Research And Development
SemBioSys Genetics has demonstrated bio-equivalence of a plant-produced insulin, which if realised, could become a viable alternative to meet the demand for insulin as the incidence of diabetes increases worldwide.
Cellectricon has launched a new chip for safety pharmacology and hERG studies, which aims to provide a solution to the current need for increased throughput and data quality in ion channel drug discovery that has plagued drug researchers.
Bayer Diagnostics launches its latest immunoassay system, part of its ADVIA family of automated clinical laboratory solutions, which enable laboratories to rapidly perform a wide variety of disease-specific tests which enhance the management of disease.
The pressures placed on pharmaceutical and biotechnology firms are causing companies to outsource their drug discovery processes as contract research organisations (CROs) expand to offer services such as finance/accounting, logistics and human...
Gedeon Richter and Forest Laboratories have expanded their collaboration by forming two additional agreements involving two novel mechanisms targeted for the treatment of CNS conditions, building upon the existing collaboration announced last year for...